Nuveen Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $688K | Hold |
123,468
| – | – | ﹤0.01% | 2868 |
|
|
2024
Q3 | $1.33M | Hold |
123,468
| – | – | ﹤0.01% | 2627 |
|
|
2024
Q2 | $2.59M | Buy |
123,468
+14,718
| +14% | +$309K | ﹤0.01% | 2258 |
|
|
2024
Q1 | $3.46M | Hold |
108,750
| – | – | ﹤0.01% | 2148 |
|
|
2023
Q4 | $2.2M | Buy |
108,750
+1,383
| +1% | +$28K | ﹤0.01% | 2368 |
|
|
2023
Q3 | $1.37M | Buy |
107,367
+10,047
| +10% | +$128K | ﹤0.01% | 2447 |
|
|
2023
Q2 | $1.76M | Sell |
97,320
-59,311
| -38% | -$1.07M | ﹤0.01% | 2401 |
|
|
2023
Q1 | $2.69M | Buy |
156,631
+27,534
| +21% | +$473K | ﹤0.01% | 2214 |
|
|
2022
Q4 | $2.87M | Sell |
129,097
-17,104
| -12% | -$380K | ﹤0.01% | 2222 |
|
|
2022
Q3 | $1.18M | Sell |
146,201
-314
| -0.2% | -$2.52K | ﹤0.01% | 2672 |
|
|
2022
Q2 | $1.02M | Buy |
146,515
+52,662
| +56% | +$367K | ﹤0.01% | 2768 |
|
|
2022
Q1 | $1.47M | Sell |
93,853
-3,473
| -4% | -$54.5K | ﹤0.01% | 2656 |
|
|
2021
Q4 | $1.93M | Buy |
97,326
+6,424
| +7% | +$128K | ﹤0.01% | 2576 |
|
|
2021
Q3 | $3.16M | Buy |
90,902
+63,980
| +238% | +$2.23M | ﹤0.01% | 2448 |
|
|
2021
Q2 | $648K | Buy |
26,922
+9,191
| +52% | +$221K | ﹤0.01% | 3128 |
|
|
2021
Q1 | $769K | Buy |
+17,731
| New | +$769K | ﹤0.01% | 2978 |
|